Sign up to save your podcasts
Or
Share 4 Keys to Allo in 2024 with Poseida Therapeutics' Kristin Yarema, Ph.D.
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
4 Keys to Allo in 2024 with Poseida Therapeutics' Kristin Yarema, Ph.D.
We love to hear from our listeners. Send us a message.
Kristin Yarema, Ph.D., CEO, Poseida Therapeutics sits down with Cell & Gene: The Podcast Host Erin Harris to discuss four of the biggest challenges the CGT sector faces when it comes to the development of off-the-shelf therapies. Kristin shares how 2024 might see some real progress in allogeneic therapies.
Subscribe to the podcast!
Apple | Spotify | YouTube
View all episodes
By Erin Harris
4.9
3838 ratings
We love to hear from our listeners. Send us a message.
Kristin Yarema, Ph.D., CEO, Poseida Therapeutics sits down with Cell & Gene: The Podcast Host Erin Harris to discuss four of the biggest challenges the CGT sector faces when it comes to the development of off-the-shelf therapies. Kristin shares how 2024 might see some real progress in allogeneic therapies.
Subscribe to the podcast!
Apple | Spotify | YouTube
More shows like Cell & Gene: The Podcast
View all
Nature Podcast
763 Listeners
Science Magazine Podcast
808 Listeners
Economist Podcasts
4,245 Listeners
Freakonomics Radio
32,055 Listeners
The Long Run with Luke Timmerman
124 Listeners
Immune
271 Listeners
The Readout Loud
318 Listeners
FT News Briefing
699 Listeners
Business Of Biotech
88 Listeners
BioCentury This Week
31 Listeners
Raising Health
146 Listeners
Biotech Hangout
11 Listeners
ASGCT Podcast Network
15 Listeners
Elon, Inc.
149 Listeners
Ground Truths
47 Listeners